Newsroom

News

The development and spread of antibiotic resistance represents one of the greatest threats to global health. To overcome these resistances, drugs with novel mode of action are urgently needed. Researchers at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) have now uncovered the mode of action of a promising class of natural products – the chlorotonils. These molecules simultaneously target the bacterial cell membrane and the bacteria’s ability to produce proteins, enabling them to break through resistance. The team published its findings in the journal Cell Chemical Biology.

15.04.2025

HIPS

HZI Campus

News

Today, around 60 schoolchildren from grades 5 to 9 visited the Helmholtz Centre for Infection Research (HZI) in Braunschweig to gain an insight into the work of a modern research institution. They were able to immerse themselves in the fascinating world of science in a total of eight different departments.

03.04.2025

HZI Campus

TWINCORE

News

On March 17 and 18, 2025, the kick-off meeting of the INFRALINK network took place at the Helmholtz Centre for Infection Research (HZI) in Braunschweig. Six partner institutions will establish a network to facilitate infection research between the public health service and research institutions. The project is being funded by the Volkswagen Foundation with 500,000 euros.

02.04.2025

HZI Campus

News

Science is currently facing major challenges in the United States – and with noticeable impacts on Europe. Research budgets have been and continue to be cut and jobs lost, even in key areas such as health and infectious diseases. A viewpoint from Josef Penninger, Scientific Director of the Helmholtz Centre for Infection Research.

01.04.2025

HZI Campus

News

An international research group led by the Helmholtz Centre for Infection Research (HZI) has discovered a promising new drug candidate against severe lung infections caused by the hospital germ Staphylococcus aureus. The study, which has just been published in Cell Host & Microbe, describes for the first time how small molecules from the quinoxalinedione class specifically block the bacterial toxin α-hemolysin – a key trigger of tissue damage and inflammation.

01.04.2025

HZI Campus

HIPS

News

Acquiring external funding is an integral part of any young scientist’s path towards an independent research career. Such additional funds not only make their own scientific success visible, but also give them freedom to implement new and possibly riskier project ideas. One funding instrument that focuses on supporting early stage researchers is the Klaus-Tschira-Boost-Fund. In the current round of applications, 15 out of more than 300 applicants were selected to receive funding of up to 120,000 Euros each – amongst them the junior researchers Mariia Nesterkina and Florian Hubrich from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS). The HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in collaboration with Saarland University. As so-called “Boost Fellows”, Mariia Nesterkina and Florian Hubrich benefit not only from the funding itself, but also from a series of workshops on career development and gain access to extensive career counseling and coaching services. The funded projects are set to start between April and October 2025 and will run for 24 months.

01.04.2025

HIPS

Back to the first page
...
11
12
13
14
...
149

HZI in the media

Medikament Tolcapon identifiziert. Das HIPS ist ein Standort des Helmholtz-Zentrums für Infektionsforschung (HZI) in Kooperation ...

01.12.2025

Homburg

... wissenschaftlicher Ko-Direktor des Helmholtz Zentrums für Infektionsforschung (HZI). Thomas Pietschmann engagiert sich seit 2023 im ...

28.11.2025

juraforum.de

Dr. Alexander Titz, group leader at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS). “Finding new ways to disrupt its

28.11.2025

ARCHYDE

... “, sagte die Leiterin der Epidemiologie am Braunschweiger Helmholtz-Zentrum für Infektionsforschung.

Lange betonte, flächendeckende ...

28.11.2025

Evangelische Zeitung

... ein Zentrum für Quantentechnologie entstehen und das Helmholtz-Institut für Pharmazeutische Forschung ausgebaut werden.

Mehr ...

27.11.2025

Tagesschau

Euro werden investiert in die Erweiterung des Helmholtz-Instituts für Pharmazeutische Forschung Saarland (HIPS). Und ...

27.11.2025

ZEIT online

s drug tolcapone. HIPS is a site of the Helmholtz Center for Infection Research (HZI) in collaboration with Saarland University.

The

26.11.2025

Medical Xpress

... erhielt das Projekt „Citrapeutics“ vom Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig eine Förderung in Höhe ...

25.11.2025

Bionity.COM

led by Hannover Medical School (MHH) and the Helmholtz Center for Infection Research (HZI) has now discovered clear molecular signatures for

24.11.2025

Medical Xpress

Medizinischen Hochschule Hannover (MHH) und dem Helmholtz-Zentrum für Infektionsforschung (HZI), hat nun eindeutige molekulare Signaturen ...

24.11.2025

DeutschesGesundheitsPortal

Braunschweig. Das Helmholtz-Zentrum für Infektionsforschung (HZI) bringt anlässlich seines 60. Jubiläums seine Forschung vom 3. ...

22.11.2025

Regional Heute

Universität Hannover (LUH), dem Helmholtz Zentrum für Infektionsforschung (HZI) in Braunschweig, der Technischen Universität Braunschweig ...

21.11.2025

Medizinische Hochschule Hannover

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.